UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039042
Receipt number R000044435
Scientific Title The suppressive effect of shivering during targeted temperature management with skin counter warming limited to extremities
Date of disclosure of the study information 2020/01/06
Last modified on 2022/03/30 11:34:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The suppressive effect of shivering during targeted temperature management with skin counter warming limited to extremities

Acronym

The suppressive effect of shivering during targeted temperature management with skin counter warming limited to extremities

Scientific Title

The suppressive effect of shivering during targeted temperature management with skin counter warming limited to extremities

Scientific Title:Acronym

The suppressive effect of shivering during targeted temperature management with skin counter warming limited to extremities

Region

Japan


Condition

Condition

Patients after cardiac arrest, traumatic brain injury or cerebrovascular accident

Classification by specialty

Emergency medicine Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The efficacy of skin counter warming limited to extremities for shivering during targeted temperature management

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The frequency and the degree of shivering during targeted temperature management

Key secondary outcomes

The change of Bedside Shivering Assessment Scale every hour
The dosage of sedatives, analgesics and neuromuscular blockers


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Warming blankets were put on all of eligible patients after the ICU admission. The following interventions continue until finishing targeted temperature management.
Group A: inflating the blanket with air heated to 43 degrees Celsius

Interventions/Control_2

Group B: inflating the blanket with room-temperature air

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients undergoing targeted temperature management with ECMO or intravascular cooling device

Key exclusion criteria

Under 18 year old
Patients who do not get consent or withdraw consent
Patients who are out of drug administration protocol

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Eichi
Middle name
Last name Narimatsu

Organization

Sapporo medical university

Division name

Emergency medicine

Zip code

0608543

Address

291 South 1 West 16, Chuo-Ku, Sapporo, Hokkaido, Japan

TEL

011-611-2111

Email

enarimat@sapmed.ac.jp


Public contact

Name of contact person

1st name Ryuichiro
Middle name
Last name Kakizaki

Organization

Sapporo medical university

Division name

Emergency medicine

Zip code

0608543

Address

291 South 1 West 16, Chuo-Ku, Sapporo, Hokkaido, Japan

TEL

011-611-2111

Homepage URL


Email

r.kakizaki@sapmed.ac.jp


Sponsor or person

Institute

Sapporo medical university
Div. of Emergency medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Sapporo medical university

Address

291 South 1 West 16, Chuo-Ku, Sapporo, Hokkaido, Japan

Tel

011-611-2111

Email

r.kakizaki@sapmed.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

札幌医科大学附属病院高度救命救急センター


Other administrative information

Date of disclosure of the study information

2020 Year 01 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

43

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 12 Month 12 Day

Date of IRB

2019 Year 12 Month 12 Day

Anticipated trial start date

2020 Year 01 Month 20 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry

2022 Year 03 Month 31 Day

Date trial data considered complete

2022 Year 03 Month 31 Day

Date analysis concluded

2022 Year 10 Month 31 Day


Other

Other related information



Management information

Registered date

2020 Year 01 Month 02 Day

Last modified on

2022 Year 03 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044435


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name